Pub. Date : 2012 Jun 15
PMID : 22414725
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Previously, we reported that lapatinib (GW572016), a human epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinase inhibitor (TKI), significantly reverses MDR in cancer cells by blocking the efflux function of ABC subfamily B member 1 (ABCB1) and ABC subfamily G member 2 (ABCG2). | Lapatinib | ATP binding cassette subfamily B member 1 | Homo sapiens |
2 | Previously, we reported that lapatinib (GW572016), a human epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinase inhibitor (TKI), significantly reverses MDR in cancer cells by blocking the efflux function of ABC subfamily B member 1 (ABCB1) and ABC subfamily G member 2 (ABCG2). | Lapatinib | ATP binding cassette subfamily B member 1 | Homo sapiens |
3 | Previously, we reported that lapatinib (GW572016), a human epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinase inhibitor (TKI), significantly reverses MDR in cancer cells by blocking the efflux function of ABC subfamily B member 1 (ABCB1) and ABC subfamily G member 2 (ABCG2). | Lapatinib | ATP binding cassette subfamily B member 1 | Homo sapiens |
4 | Previously, we reported that lapatinib (GW572016), a human epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinase inhibitor (TKI), significantly reverses MDR in cancer cells by blocking the efflux function of ABC subfamily B member 1 (ABCB1) and ABC subfamily G member 2 (ABCG2). | Lapatinib | ATP binding cassette subfamily B member 1 | Homo sapiens |
5 | In the present study, we conducted in vitro experiments to evaluate if GW583340 and GW2974, structural analogues of lapatinib, could reverse ABCB1- and ABCG2-mediated MDR. | Lapatinib | ATP binding cassette subfamily B member 1 | Homo sapiens |